Skip to main content

Advertisement

SpringerLink
Log in

Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia

A pilot study

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

The present study was designed to determine whether Filgrastim, a neutrophil-specific hematopoietic growth factor, could be administered simultaneously with intensive induction chemotherapy for adult acute lymphoblastic leukemia (ALL). The effect of Filgrastim on the severity of chemotherapy-induced neutropenia, fever, and infections was assessed in 15 patients treated according to the protocol of the German multicenter ALL (GMALL) trial 04/89. Filgrastim (5μg/kg/day) was given concurrently with successive cycles of cyclophosphamide, cytosine-arabinoside (ara-C), 6-mercaptopurine (6MP), prednisone (PRD), intrathecal methotrexate, and prophylactic cranial irradiation. During the study period the median total duration of severe neutropenia (<0.5×109/l) in 13 evaluable patients was 8 days, individual periods of neutropenia typically were short. Infections occurred in six patients; seven patients remained fever-free during treatment with Filgrastim. We conclude that simultaneous treatment with Filgrastim and chemotherapy in this specific setting is feasible and well tolerated. The efficacy of this treatment approach in terms of overall treatment results requires further testing in a randomized trial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bettelheim P, Valent M, Andreeff M, Tafuri A, Haimi J, Gorischek C, Muhm M, Sillaber C, Haas O, Vieder L, Maurer D, Schulz G, Speiser W, Geissler K, Kier P, Hinterberger W, Lechner K (1991) Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia. Blood 77:700–711

    PubMed  Google Scholar 

  2. Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 84:328–340

    Google Scholar 

  3. Büchner T, Hiddemann W, Koenigsmann M, Zühlsdorf M, Wörmann B, Boeckmann A, Freire EA, Innig G, Maschmeyer G, Ludwig WD, Sauerland M-C, Heinecke A, Schulz G (1991) Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse. Blood 78:1190–1197

    PubMed  Google Scholar 

  4. Büchner T, Hiddemann W, Wörmann B, Rottmann R, Zühlsdorf M, Maschmeyer G, Heit W, Ludwig W-D, Thiel E, Sauerland M-C (1992) Multiple course chemotherapy and GM-CSF from day minus one until neutrophil recovery versus chemotherapy alone in newly diagnosed AML. Ann Hematol G4:A78 (abstr)

    Google Scholar 

  5. Cannistra SA, DiCarlo J, Groshek P, Kanakura Y, Berg D, Mayer RJ, Griffin JD (1991) Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia. Leukemia 5:230–238

    PubMed  Google Scholar 

  6. Clarkson B, Ellis S, Little C, Gee T, Arlin Z, Mertelsmann R, Andreeff M, Kempin S, Koziner B, Chaganti R, Jhanwar S, McKenzie S, Cirrincione C, Gaynor J (1985) Acute lymphoblastic leukemia in adults. Semin Oncol 12:160–179

    Google Scholar 

  7. Davis I, Morstyn G (1991) The role of granulocyte colony-stimulating factor in cancer chemotherapy. Semin Hematol 28:25–33

    Google Scholar 

  8. Estey EH, Dixon D, Kantarjian HM, Keating MJ, McCredie K, Bodey GP, Kurzrock R, Talpaz M, Freireich EJ, Deisseroth AB, Gutterman JU (1990) Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with Ara-C and recombinant human granulocyte-macrophage colony-stimulating factor. Blood 75:1766–1769

    PubMed  Google Scholar 

  9. Glaspy JA, Golde DW (1990) Clinical trials of myeloid growth factors. Exp Hematol 18:1137–1141

    PubMed  Google Scholar 

  10. Hiddemann W, Niederle N, von Pawel J, Gatzemeier U, Macha N, Nowrousian M, Graf M, Gracien E (1992) Treatment of NSCLC with Escalated doses of carboplatin/vindesine followed by rG-CSF versus standard-dose therapy: interim results of a prospective randomized comparison. J Cancer Res Clin Oncol 118:[SuppI] 3–4 (abstract)

    Google Scholar 

  11. Hoelzer D, Gale RP (1987) Acute lymphoblastic leukemia in adults: recent progress, future directions, Semin Hematol 24:27–39

    PubMed  Google Scholar 

  12. Hoelzer D, Thiel E, Bodenstein H, Plaumann L, Büchner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, Müller U, Wendt F-C, Sodomann H, Rühl H, Herrmann F, Kaboth H, Dietzfelbinger H, Pralle H, Lunscken C, Hellriegel K-P, Spors S, Nowrousian RM, Fischer J, Fülle H, Mitrou PS, Pfreundschuh M, Görg C, Emmerich B, Queisser W, Meyer P, Labedzki L, Essers U, König H, Mainzer K, Herrmann R, Messerer D, Zwingers T (1984) Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 64:36–47

    Google Scholar 

  13. Hoelzer D, Thiel E, Loeffler H, Büchner T, Ganser A, Heil G, Kurrle E, Heimpel H, Koch P, Lipp T, Kaboth W, Kuse R, Küchler R, Sodomann H, Maschmeyer G, Freund M, Diedrich H, von Paleske A, Weh J, Kolb H, Müller U, Bross K, Fuhr G, Gassmann W, Gerecke D, Kress M, Busch FW, Nowrousian RM, Schneider W, Aul C, Rühl H, Bartels H, Harms F, Weiss A, Löffler B, Glöckner W, Fülle H, Pralle H, Ho AD, Bonfert B, Emmerich B, Braumann D, Brenner-Serke M, Planker M, Straif K, Meyer P, Greil R, Petsch S, Görg C, Grüneisen A, Vaupel HA, Bodenstein H, Overkamp F, Schlimock G, Augener W, Ohl S, Nowicki L, Raeth U, Zurborn KH, Neiss A, Messerer D (1987) Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia. Semin Oncol 14:92–97 [Suppl 1]

    PubMed  Google Scholar 

  14. Hoelzer D, Thiel E, Loeffler H, Büchner T, Ganser A, Heil G, Koch P, Freund M, Diedrich H, Rühl H, Maschmeyer G, Lipp T, Nowrousian MR, Burkert M, Gerecke D, Pralle H, Müller U, Lunscken C, Fülle H, Ho AD, Küchler R, Busch FW, Schneider W, Görg C, Emmerich B, Braumann D, Vaupel HA, von Paleske A, Bartels H, Neiss A, Messerer D (1988) Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71:123–131

    PubMed  Google Scholar 

  15. Kleine H-D, Wagner U, Poliwoda H, Freund M (1992) Effects of tumor necrosis factor alpha on bone marrow aspirates of patients with acute myelogenous leukemia determined by flow-cytometric cell-cycle analysis. J Cancer Res Clin Oncol 118:56–60

    PubMed  Google Scholar 

  16. Linker CA, Levitt LJ, O'Donnel M, Ries CA, Link MP, Forman SJ, Farbstein MJ (1987) Improved results of treatment of adult acute lymphoblastic leukemia. Blood 69:1242–1248

    PubMed  Google Scholar 

  17. Meropol NJ, Miller LL, Korn EL, Braitman LE, MacDermott ML, Schuchter LM (1991) The coadministration of granulocyte colony-stimulating factor and cytotoxic chemotherapy results in severe paradoxical myelosuppression. Blood 78:3a [Suppl 1]

    Google Scholar 

  18. Ohno R, Tomonaga M, Kobayashi T, Kanamaru A, Shirakawa S, Masaoka T, Omine M, Oh H, Nomuro T, Sakai Y, Hirano M, Yokomaku S, Nakayama S, Yoshida Y, Miura AB, Morishima Y, Dohy H, Niho Y, Hamajima N, Takaku F (1990) Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N Engl J Med 123:871–877

    Google Scholar 

  19. Scherrer R, Geissler K, Kyrle PA, Gisslinger H, Jäger U, Bettelheim P, Laczika K, Locker G, Scholten C, Sillaber C, Schwarzinger I, Thalhammer F, Lechner K (1993) Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult lymphoblastic leukemia (ALL). Ann Hematol 66:283–289

    PubMed  Google Scholar 

  20. Teshima H, Ishikawa J, Kitajama H, Yamagami T, Hiraoka A, Nakamura H, Shibata H, Masaoka T, Takaku F (1969) Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients; a phase I/II study. Exp Hematol 17:853–858

    Google Scholar 

  21. Tsuchiya H, Adachi N, Asou N, Takatsuki K, Matsuda I, Kawana F, Murakami T, Mizutani S, Watanabe M (1991) Responses to granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage CSF in PH1-positive acute lymphoblastic leukemia with myeloid surface markers. Blood 77:411–413

    Google Scholar 

  22. Tsukimoto I, Ohara A, Tanaka M, Tsuchida M, Hanawa Y (1992) Effect of rG-CSF on relapsed acute lymphoblastic leukemia in children. Ann Hematol 64:A81 (abstr)

    Google Scholar 

  23. Weite K, Bonilla MA, Gillio AP, Boone TC, Potter GK, Gabrilove JL, Moore MAS, O'Reilly RJ, Souza LM (1987) Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamidetreated primates. J Exp Med 165:941–948

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Hematology, Universities of Frankfurt, Hannover

    O. G. Ottmann, A. Ganser, M. Freund, G. Heil, W. Hiddemann, W. Heit, E. Gracien & D. Hoelzer

  2. Departments of Hematology, Universities of Frankfurt, Ulm

    O. G. Ottmann, A. Ganser, M. Freund, G. Heil, W. Hiddemann, W. Heit, E. Gracien & D. Hoelzer

  3. Departments of Hematology, Universities of Frankfurt, Münster

    O. G. Ottmann, A. Ganser, M. Freund, G. Heil, W. Hiddemann, W. Heit, E. Gracien & D. Hoelzer

  4. Evangelische Krankenhaus Essen-Werden, and Amgen GmbH, Munich, Germany

    O. G. Ottmann, A. Ganser, M. Freund, G. Heil, W. Hiddemann, W. Heit, E. Gracien & D. Hoelzer

Authors
  1. O. G. Ottmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Ganser
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Freund
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Heil
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. Hiddemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Heit
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Gracien
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D. Hoelzer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ottmann, O.G., Ganser, A., Freund, M. et al. Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia. Ann Hematol 67, 161–167 (1993). https://doi.org/10.1007/BF01695862

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01695862

Key words

Search

Navigation